id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-P-0158-0003,FDA,FDA-2004-P-0158,Change in Classification of Petition from Roche Diagnostics Corporation,Other,Change in Classification Petition,2018-06-21T04:00:00Z,2018,6,2004-01-28T05:00:00Z,,2024-12-04T21:03:03Z,,0,0,090000648047004f
FDA-2004-P-0158-0002,FDA,FDA-2004-P-0158,Medical Devices; Hematology and Pathology Devices; Classification of the Factor V Leiden DNA Mutation Detection Systems Devices,Rule,Final Rule,2004-03-24T05:00:00Z,2004,3,2004-03-15T05:00:00Z,2004-03-17T04:59:59Z,2024-12-04T20:55:57Z,04–5864,0,0,0900006480470050
FDA-2004-P-0158-0001,FDA,FDA-2004-P-0158,Response Letter from FDA CDRH to Roche Diagnostics Corporation,Other,Letter(s),2004-01-29T05:00:00Z,2004,1,2003-12-17T05:00:00Z,,2024-12-04T20:50:17Z,,0,0,090000648047004c